A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2006
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1341809B1 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
11/02/2006	EP1296636B1 USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES
11/02/2006	EP1284984B1 Uridine derivatives as antibiotics
11/02/2006	EP1276760B1 Polyamide nucleic acid derivatives, agents and methods for producing them
11/02/2006	EP1261629B1 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
11/02/2006	EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1194144B1 Antibacterial compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1144005B1 Treatment of papillomavirus infections
11/02/2006	EP1143959B1 Antifungal activity of dicationic molecules
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1058686B1 2'-fluoronucleosides
11/02/2006	EP1006785B1 Antimicrobial proteins
11/02/2006	EP1003874B1 Neisseria lactoferrin binding protein
11/02/2006	EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
11/02/2006	DE102005020457A1 Use of non-pathogenic sporulating bacteria for inhibiting the growth of infectious germs on the udder and/or teat of a lactating mammal
11/02/2006	CA2609927A1 Methods and means for the treatment of hpv induced intraepithelial neoplasias
11/02/2006	CA2606251A1 Imidazo(1,2-a)pyridine derivatives useful as peptide deformylase (pdf) inhibitors
11/02/2006	CA2606025A1 Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
11/02/2006	CA2605925A1 Imidazo [1, 2-a] pyridine derivatives useful as peptide deformylase (pdf) inhibitors
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605275A1 Use of vitamin e tocotrienols for the inhibition of intracellularly obligate pathogen chlamydia
11/02/2006	CA2571710A1 Small molecule immunopotentiators and assays for their detection
11/01/2006	CN1856575A DNA transfection system for the generation of infectious influenza virus
11/01/2006	CN1856508A Human monoclonal antibody fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity
11/01/2006	CN1856503A Peptide originating in hepatitis c virus
11/01/2006	CN1856502A Macrocyclic peptides active against the hepatitis c virus
11/01/2006	CN1856496A HIV-replikasjonshemmede purinderivater
11/01/2006	CN1856495A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856494A Imidazopyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856493A Aminopyridine-derivatives as inductible NO-synthase inhibitors
11/01/2006	CN1856492A Imidazo(4,5-B)pyridine-derivatives as inducible NO-synthase inhibitors
11/01/2006	CN1856491A Imidazopyridine-derivatives as inductible NO-synthase inhibitors
11/01/2006	CN1856322A Microsome vaccine
11/01/2006	CN1856302A Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir)
11/01/2006	CN1854284A Vinegar with cough-preventing function
11/01/2006	CN1854139A Levo ofloxacin derivative, its production and use
11/01/2006	CN1853731A Use of staphylococcal enterotoxin A gene and its coded protein
11/01/2006	CN1853726A Polymer system for improving insoluble medicine water solubility and preparation thereof
11/01/2006	CN1853724A Compound injection with probenecid, potassium and beta-lactam antibiotic and its use
11/01/2006	CN1853721A Schweineseuche O-shaped synthetic peptide vaccine and preparation thereof
11/01/2006	CN1853718A Positioning composition for oral liquid and its preparation
11/01/2006	CN1853714A Wuren alcohol soft capasule and preparation thereof
11/01/2006	CN1853679A Medicinal composition for treating cervical spondylosis and preparation thereof
11/01/2006	CN1853669A Swertia milleensis general glycoside drip balls and preparation thereof
11/01/2006	CN1853665A Effective antiviral part of isatis root
11/01/2006	CN1853644A Treatment and prophylaxis of diseases and infections pigs and poultry
11/01/2006	CN1853641A Glycyrrhiza edulcorant drip ball and production thereof
11/01/2006	CN1853640A Doxycycline hyclate liposome and production thereof
11/01/2006	CN1853635A Use of triazinetrione sulfones for combating coccidiosis
11/01/2006	CN1853634A Composition comprising itraconazole for oral administration
11/01/2006	CN1853629A Berberine dripping balls and preparation thereof
11/01/2006	CN1853620A Fat emulsion of houttuynin analog
11/01/2006	CN1853614A Decoloring method and decoloring agent for quinolone injection
11/01/2006	CN1853480A Broad-spectrum antiseptics and production thereof
11/01/2006	CN1282748C Method for preparing leukocyte interferon of pig
11/01/2006	CN1282656C HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines
11/01/2006	CN1282649C Corter pseudolaricis acid derivatives, preparation method and use thereof
11/01/2006	CN1282636C Vitamin D analogues
11/01/2006	CN1282486C Vaccine compsn. comprising at least two valences, one enhanced with adjuvant and not other
11/01/2006	CN1282460C Chinese traditional medieine for treating cold and preparing technique
11/01/2006	CN1282458C Cefadroxil dry suspension and preparing method
11/01/2006	CN1282452C Use of aminoadamantane compound as immunoregulators
10/2006
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129349 Methods of synthesizing 3-amino-1,2,4-benzotriazines
10/31/2006	US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide
10/31/2006	US7129275 Compositions for treating acne comprising phytandiol amine
10/31/2006	US7129251 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129232 For therapy of of infectious diseases
10/31/2006	US7129227 Herpes, hepatitis and aids virus; administering phosphatides
10/31/2006	US7129222 Immunomodulatory formulations and methods for use thereof
10/31/2006	US7129037 Delivering antigen to dendritic cells by contacting dendritic cells with apopototic cells expressing an antigen to allow antigen to be internalized by the dendritic cells, and wherein apoptotic cells have been induced in vitro to become apoptotic
10/31/2006	US7128913 Erythropoietin conjugates
10/31/2006	US7128905 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated.
10/31/2006	US7128897 Having surface tension, effective for therapy of respiratory systme disorders
10/31/2006	CA2333405C Spill resistant pharmaceutical compositions
10/31/2006	CA2283457C Polyvalent carbohydrate molecules
10/31/2006	CA2267160C Antimycotic gel for the treatment and prevention of skin mycoses
10/31/2006	CA2265686C A crystalline substance of cefditoren pivoxyl and the production of the same
10/31/2006	CA2262906C Novel immunotherapeutic agents and their use in the reduction of cytokine levels
10/31/2006	CA2243755C Streptococcal c5a peptidase vaccine
10/31/2006	CA2157376C Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
10/31/2006	CA2142811C Novel glucan preparation
10/31/2006	CA2141410C Tetanus vaccine production
10/31/2006	CA2136953C A method for using lipoprotein associated coagulation inhibitor to treat sepsis
10/26/2006	WO2006113942A2 Method of inhibiting cathepsin activity
10/26/2006	WO2006113772A1 C. perfringens alpha toxoid vaccine
10/26/2006	WO2006113209A1 Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
10/26/2006	WO2006112694A2 Nutritional supplement with colostrum and epa or dha or gla
10/26/2006	WO2006112477A1 Polyamino acid for use as adjuvant
10/26/2006	WO2006112442A1 Benzimidazole compound
10/26/2006	WO2006112441A1 Anti-hepatitis c virus agent containing bmp-7
10/26/2006	WO2006112331A1 Novel condensed pyrrole derivative
10/26/2006	WO2006111844A1 Use of azithromycin for the production of a medicament for treatment of ocular infections
10/26/2006	WO2006111716A1 Heteroaryl derivatives having anti-mycobacterial activity

1 ... 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 ... 1798